Your browser doesn't support javascript.
loading
Enhanced anticancer activity by the combination of vinpocetine and sorafenib via PI3K/AKT/GSK-3ß signaling axis in hepatocellular carcinoma cells.
Zhang, Zuo-Yan; Dong, Shu-Min; Liu, Ye-Han; Zhang, Man-Man; Zhang, Jian-Kang; Zhu, Hua-Jian; Shao, Jia-An; Liu, Hua-Qing; Li, Yang-Ling; Zhang, Chong; Zeng, Ling-Hui.
Affiliation
  • Zhang ZY; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Dong SM; Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University.
  • Liu YH; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Zhang MM; Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University.
  • Zhang JK; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Zhu HJ; Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University.
  • Shao JA; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Liu HQ; Department of Pharmacology, College of Pharmaceutical Sciences, Zhejiang University.
  • Li YL; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Zhang C; Department of Pharmacology, School of Medicine, Zhejiang University City College.
  • Zeng LH; Department of Pharmacology, School of Medicine, Zhejiang University City College.
Anticancer Drugs ; 32(7): 727-733, 2021 08 01.
Article in En | MEDLINE | ID: mdl-33735117
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vinca Alkaloids / Phosphatidylinositol 3-Kinases / Glycogen Synthase Kinase 3 beta / Sorafenib Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Vinca Alkaloids / Phosphatidylinositol 3-Kinases / Glycogen Synthase Kinase 3 beta / Sorafenib Limits: Humans Language: En Journal: Anticancer Drugs Journal subject: ANTINEOPLASICOS Year: 2021 Document type: Article Country of publication: United kingdom